Quarterly report [Sections 13 or 15(d)]

Insider Trading Arrangements

v3.25.1
Insider Trading Arrangements
3 Months Ended
Apr. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities set forth in the table below.
Type of Trading Arrangement
Name and Position
Action
Adoption/ Termination
Date
Rule 10b5-1*
Non-
Rule 10b5-1**
Total Shares of Class A Common Stock to be Sold
Expiration Date
Manish Sarin, Chief Financial Officer
Adoption
March 20, 2025
X
380,284(1)
December 31, 2025
Jacob Scott, General Counsel & Corporate Secretary
Adoption
March 21, 2025
X
113,665(2)
December 31, 2025
Scott Harvey, Chief Customer Officer
Adoption
March 27, 2025
X
339,859(3)
March 31, 2026
Arunkumar Pattabhiraman, Chief Marketing Officer
Adoption
March 27, 2025
X
295,491(4)
March 26, 2026
* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
(1) Includes up to 217,083 shares subject to restricted stock units (“RSUs”) previously granted to Mr. Sarin that will vest and be released to Mr. Sarin on or prior to December 15, 2025. The actual number of shares underlying such RSUs that will be released to Mr. Sarin and sold under the Rule 10b5-1 trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not determinable at this time.
(2) The actual number of shares to be sold under the Rule 10b5-1 trading arrangement will be determined, in part, based on a cap on the net proceeds from their sale and is not determinable at this time.
(3) Includes up to 218,802 shares subject to RSUs previously granted to Mr. Harvey that will vest and be released to Mr. Harvey on or prior to March 15, 2026. The actual number of shares underlying such RSUs that will be released to Mr. Harvey and sold under the Rule 10b5-1 trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not determinable at this time.
(4) Includes up to 211,746 shares subject to RSUs previously granted to Mr. Pattabhiraman that will vest and be released to Mr. Pattabhiraman on or prior to March 15, 2026. The actual number of shares underlying such RSUs that will be released to Mr. Pattabhiraman and sold under the Rule 10b5-1 trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not determinable at this time.
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Manish Sarin [Member]  
Trading Arrangements, by Individual  
Name Manish Sarin,
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 20, 2025
Expiration Date December 31, 2025
Arrangement Duration 286 days
Aggregate Available 380,284
Jacob Scott [Member]  
Trading Arrangements, by Individual  
Name Jacob Scott,
Title General Counsel & Corporate Secretary
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 21, 2025
Expiration Date December 31, 2025
Arrangement Duration 285 days
Aggregate Available 113,665
Scott Harvey [Member]  
Trading Arrangements, by Individual  
Name Scott Harvey,
Title Chief Customer Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 27, 2025
Expiration Date March 31, 2026
Arrangement Duration 369 days
Aggregate Available 339,859
Arunkumar Pattabhiraman [Member]  
Trading Arrangements, by Individual  
Name Arunkumar Pattabhiraman,
Title Chief Marketing Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 27, 2025
Expiration Date March 26, 2026
Arrangement Duration 364 days
Aggregate Available 295,491